Home / Healthcare/ GSK to shut Bangladesh drug-making factory by 2018

GSK to shut Bangladesh drug-making factory by 2018


Comments / {{hitsCtrl.values.hits}} Views / Tuesday, 31 July 2018 00:00


DHAKA (Reuters): GlaxoSmithKline will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare business, the managing director of its local businesses said on Friday.

Globally, GSK’s pharmaceuticals business has seen sluggish growth in recent years. The company unveiled a new restructuring program to deliver annual cost savings of GBP 400 million by 2021.

Nakibur Rahman said the board of GSK Bangladesh Ltd. last Thursday decided to close the drug-making factory in Bangladesh.

He said GSK Bangladesh would continue with its profitable consumer healthcare business that produces items like Horlicks, Sensodyne and Glaxose-D.

 “All of our medicines are substitutable with generic and therefore, patients should be able to access a range of suitable alternatives,” Nakibur said. He also said the company’s decision would impact about 1,000 employees. GSK Bangladesh will now seek shareholders’ nod for a final decision.

 “GSK will run pharmaceuticals in our emerging markets region as an integrated operation, putting in place the right commercial structure in markets to deliver a sustainable growth ambition,” Nakibur said without elaborating further.

The State-run Investment Corporation of Bangladesh owns 12% stake in the company, while 6% of the shares are held by public and different institutions.


Share This Article


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Maximum Residue Level: Dilemma of agricultural product exporters in Sri Lanka

Wednesday, 19 September 2018

Due to increased emphasis on consumer health, majority of developed countries such as EU, Japan and the US insist on MRL testing of food items which has to be done by the exporter. The Codex Alimentarius Commission which is an inter-governmental bod


East Container Terminal blunder: Learn from Chinese

Tuesday, 18 September 2018

Minister for Ports and Shipping Mahinda Samarasinghe informed the press in August that Cabinet has approved the development of East Container Terminal (ECT) of Colombo Port by the Ports Authority. According to approval: nPorts Authority would develop


President Sirisena, playing with fire, must take note that smoke will get into his eyes

Tuesday, 18 September 2018

Penchant for playing with fire President Gamaralalage Sirisena has always had a penchant for playing with fire. He did fire-play at the local government elections when he made a disastrous U-turn and went round country blasting the party and its lea


Response to claims that Sri Lanka was in a ‘debt trap’ in 2014 due to ‘Chinese loans’

Monday, 17 September 2018

Several Western analysts have carried out a relentless media campaign in keeping with their own geopolitical agenda, to suggest that China was luring Sri Lanka into a carefully engineered debt trap.


Columnists More